Month: August 2022
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research universities and medical centers.
Ocean Biomedical’s initial core portfolios in oncology, fibrosis, and infectious diseases – all based on new target discoveries enabling first-in-class drug and vaccine candidates – have been developed through grants totaling $123.9 million.
Key members of Ocean Biomedical’s experienced management team have demonstrated strategic, scientific, and commercial expertise in the biopharma industry.
The combined company is designed to have a diversified pipeline with multiple ‘shots-on-goal’ across varying indications and therapeutic areas, built from relationships with leading research institutions.
The combined company plans to leverage its core portfolios...
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ
Written by Customer Service on . Posted in Public Companies.
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research universities and medical centers.
Ocean Biomedical’s initial core portfolios in oncology, fibrosis, and infectious diseases – all based on new target discoveries enabling first-in-class drug and vaccine candidates – have been developed through grants totaling $123.9 million.
Key members of Ocean Biomedical’s experienced management team have demonstrated strategic, scientific, and commercial expertise in the biopharma industry.
The combined company is designed to have a diversified pipeline with multiple ‘shots-on-goal’ across varying indications and therapeutic areas, built from relationships with leading research institutions.
The combined company plans to leverage its core portfolios...
ResGreen Group Introduces Wireless Foot Pedals As Part of Its Wireless Automation Devices Portfolio
Written by Customer Service on . Posted in Public Companies.
ResGreen Group International, Inc., a next-gen mobile robot and software solutions company, announced today it is now offering wireless foot pedals as part of its growing portfolio of industrial automation devices
ResGreen introduces new wireless foot pedals as part of its industrial automation devices portfolioSHELBY TOWNSHIP, MI, Aug. 31, 2022 (GLOBE NEWSWIRE) — ResGreen Group International, Inc. (OTC PINK: RGGI) (“RGGI”), a next-gen mobile robot and software solutions company, announced today it is now offering wireless foot pedals as part of its growing portfolio of industrial automation devices. Foot pedals or switches are ideal for applications that require hands-free operation in warehouses, manufacturing facilities and more. Foot pedals perform similar tasks as pushbuttons and allow workers to interface with equipment...
Water Ways Technologies: Earnings Call – Q2 2022 Results and Hidrotop Acquisition
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) (“Water Ways” or the “Company“), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, announces that on Thursday, September 1, 2022, at 9 am Eastern Time, the Company will host a live webinar with a corporate update, earnings discussion and a discussion on the Hidrotop acquisition. An Investor question-and-answer session will follow.
Register: Water Ways Technologies: Q2 Earnings Call and Hidrotop Acquisition
About Water Ways Technologies Inc.WWT through its subsidiaries, is a global provider of Israeli-based agriculture technology, providing water irrigation...
Stock Yards Bancorp to Participate in the Raymond James U.S. Bank and Banking on Tech Conferences
Written by Customer Service on . Posted in Public Companies.
LOUISVILLE, Ky., Aug. 31, 2022 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO and T. Clay Stinnett, EVP and CFO, will participate in the Raymond James U.S. Bank Conference to be held September 7th, and will participate in a series of one-on-one meetings with institutional investors.
Management’s discussion materials to be used at this conference will be posted to the investor section of the Company’s website, www.syb.com, on or before September 7, 2022.
Louisville, Kentucky-based Stock Yards Bancorp, Inc., with $7.6 billion in assets, was incorporated in 1988 as...
Revival Gold Provides Update on Various Property Agreements
Written by Customer Service on . Posted in Public Companies.
Figure 1
Beartrack-Arnett Property Position (August 2022)TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), is pleased to provide an update on the status of agreements to acquire certain property interests that comprise part of the Beartrack-Arnett Gold Project (“Beartrack-Arnett”) located in Lemhi County, Idaho, USA.
Beartrack Property
On August 30th, 2022, Revival Gold executed an Amended and Restated Stock Purchase Agreement and Exploration Agreement with Meridian Gold Company (“Meridian”) (a wholly owned subsidiary of Yamana Gold Inc.) under which Revival Gold and Meridian agreed to extend the period of time for Revival Gold to complete earn-in obligations to acquire Meridian Beartrack Co. (owner of the Beartrack property and related infrastructure) by...
iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
Written by Customer Service on . Posted in Public Companies.
LEXINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022.
Dr. Ianelli’s corporate presentation will be available on-demand starting Monday, September 12, 2022 at 7:00 a.m. ET for all registrants of the conference. To attend, please register here.
For more information about the conference, or to schedule a one-on-one meeting with iSpecimen’s management...
Sensei Biotherapeutics Announces New Preclinical Data Demonstrating Favorable Pharmacokinetic and Immunologic Effects of SNS-101, a pH-selective VISTA-blocking Antibody
Written by Customer Service on . Posted in Public Companies.
BOSTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer, today reported preliminary preclinical data from mouse and non-human primate studies of SNS-101, a monoclonal antibody targeting the immune checkpoint VISTA (V-domain Ig suppressor of T cell activation).
“These preclinical data demonstrate that our conditionally active, pH-selective antibody successfully overcomes pharmacokinetic issues associated with targeting the VISTA immune checkpoint, including target-mediated drug disposition and cytokine release syndrome, in these models. The data also differentiate SNS-101 from non-selective antibodies by showing expansion of naïve and memory T cell phenotypes in vivo, as well as significant...
Bolt Biotherapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
REDWOOD CITY, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immuno-oncology therapeutics for the treatment of cancer, today announced that management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022, at 12:20 p.m. ET (9:20 a.m. PT) in New York, New York.
A live webcast of the fireside chat will be available on the Events and Presentations page of Bolt’s website at www.boltbio.com. Archived replays will be available for 30 days following the event.
About Bolt Biotherapeutics, Inc. Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing novel immuno-oncology therapeutics for the treatment of cancer. Bolt Biotherapeutics’ pipeline candidates...
GZ6G Technologies to Host Virtual Revenue Roadmap Webinar for Shareholders
Written by Customer Service on . Posted in Public Companies.
LAS VEGAS, NV, Aug. 31, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – GZ6G Technologies Corp. (OTCQB: GZIC), an enterprise smart solutions provider for cities, stadiums, universities, and other large venues, announced today that Coleman Smith, the Company’s Founder and CEO, will host a virtual webinar on September 8, 2022, in order to share highlights of the Company’s current and planned revenue generation, operational plans moving forward, and lead generation strategies.
Webinar for Shareholders -Revenue Roadmap
Date: Thursday, September 8, 2022Time: 1:30 p.m. PT / 4:30 p.m. ETRegistration: https://ir.gz6g.com/webinar/
Topics that will be covered during the presentation include:Brief Company overview including 2020-22 timeline
Simple business model for long-term growth
Large and small agreements within Networks and Media divisions...